Subcutaneous omalizumab for people with asthma

Author:

Donovan Tim1,Milan Stephen J2,Adatia Adil3,Solkar Zarina4,Stovold Elizabeth5,Dwan Kerry6,Hinks Timothy SC7,Crossingham Iain8

Affiliation:

1. Medical Sciences, Institute of Health; University of Cumbria; Lancaster UK

2. Health Innovation Campus and Centre for Health Futures; Lancaster University; Lancaster UK

3. Department of Medicine; McMaster University; Hamilton Canada

4. Lancaster UK

5. Cochrane Airways, Population Health Research Institute; St George's, University of London; London UK

6. Review Production and Quality Unit, Editorial & Methods Department; Cochrane Central Executive; London UK

7. Respiratory Medicine Unit, Nuffield Department of Medicine; University of Oxford; Oxford UK

8. East Lancashire Hospitals NHS Trust; Blackburn UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference31 articles.

1. Asthma severity and medical resource utilisation;Antonicelli;European Respiratory Journal,2004

2. Association of asthma with serum IgE and skin test reactivity to allergens;Burrows;New England Journal of Medicine,1989

3. Cochrane Airways Trials Register airways.cochrane.org/trials-register

4. Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation;Efthimiou;European Respiratory Journal,2019

5. Accelerated dissociation of IgE-FcepsilonRI complexes by disruptive inhibitors actively desensitizes allergic effector cells;Eggel;Journal of Allergy and Clinical Immunology,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3